MONTE ROSA THERAPEUTICS INC (GLUE)
Sector: Health Care
Sector: Health Care
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Markus Warmuth, M.D. Chief Executive Officer | 2025 | $650,000 | $0 | $910,080 | $3,043,648 | $429,000 | $0 | $5,032,728 |
| 2024 | $616,400 | $0 | $0 | $1,469,981 | $354,430 | $0 | $2,440,811 | |
| 2023 | $616,400 | $0 | $0 | $2,702,530 | $308,200 | $0 | $3,627,130 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Filip Janku, M.D., Ph.D. Chief Medical Officer | 2025 | $520,000 | $0 | $255,960 | $852,221 | $299,600 | $14,000 | $1,941,781 |
| 2024 | $500,000 | $0 | $0 | $514,069 | $230,000 | $13,800 | $1,257,869 | |
| 2023 | $500,000 | $0 | $0 | $772,970 | $200,000 | $13,200 | $1,486,170 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Phil Nickson, Ph.D. Chief Business and Legal Officer | 2025 | $520,000 | $0 | $255,960 | $852,221 | $299,600 | $14,000 | $1,941,781 |
| 2024 | $473,611 | $0 | $0 | $582,827 | $217,390 | $13,800 | $1,287,628 | |
| 2023 | $432,000 | $0 | $0 | $707,983 | $172,800 | $13,200 | $1,325,983 |